The IBIS Network recently received a $9.5 million grant from NIH to replicate our previous study of brain and behavior development in infants at risk for developing autism. The goal of our new study is to identify the symptoms of autism at an earlier age. We will be recruiting 250 infants across all IBIS Network locations 6-months of age and younger from families we have not previously seen. All infants we see will have at least one full older, full sibling diagnosed with autism spectrum disorder.

1. Are you 18 years of age or older? 2. Have you been diagnosed with a blood clot in the past? (more than 3 months ago) 2. Do you have leg heaviness, fatigue, swelling, aching or pain? If you answered all three questions "YES" then you might be a perfect fit for the C-TRACT study.

Do you have an advanced form of cancer? Has your cancer not responded well to previous therapies and for which no other curative therapies exist? If so, you may be eligible for a research study that uses your own modified blood cells as a possible new treatment.

Do you have epithelial ovarian cancer? Have you already been treated, but your cancer has not improved or returned? If so, you may be eligible to participate in a research study that will help us learn more about using your own modified cells as a possible treatment.

Do you have cancer? Are you about to start immunotherapy? You may be able to participate in a research study to help answer many questions that still exist about immunotherapy like - Who is more likely to get side effects? What treatments will help control the side effects but let patients continue their cancer treatment? What factors can affect the type of side effects patients have (type of cancer or immunotherapy? previous chemo or radiation? existing autoimmune diseases?, etc.) and more.

Are you currently pregnant and planning to deliver at UNC? If so, you and your baby may be eligible to take part in an exciting research opportunity! The SUNBEAM study will examine factors that lead to the development of food allergies and eczema (chronic itchy skin) in young babies and toddlers. Compensation will be provided for completed study activities.

Do you have a histologically or cytologically confirmed advanced or metastatic solid tumor? If so, you may be eligible to participate in a first-in-human, Phase 1/1b, open-label, multicenter clinical study of ERAS-601 as a monotherapy and in combination with cetuximab or pembrolizumab.

Do you have metastatic breast cancer? Are you looking for another treatment option? You may be able to participate in a new research study comparing treatments for metastatic breast cancer.

Join UNC researchers in studying hard-to-treat depression! We are researching the genetics of people with major depressive disorder or bipolar disorder who have received or been recommended for psychiatric treatments like ECT, TMS, esketamine, or ketamine.

Are you a healthy person? Have you wanted to get involved in clinical research in lung diseases? If so, you can join our registry list of interested individuals through a quick online form. We will give you a call if there are studies that you may be eligible for.